Angel Scale Biotech: Learn More
Paul Hartung is an angel investor involved in the life sciences field. Here, he discusses how he helps build companies such as Leuko, Clairways, Verisense, and others in the MedTech space.
Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.
Highlights:
- Sal Daher Introduces Paul Hartung
- Leuko Labs
- "... Something dark goes through, that's a red blood. Something light goes through, that's a white blood cell. Then they count that, and then it can come up with immunocompromised, or low leukocyte count, or normal leukocyte count..."
- Upcoming Milestones for Leuko
- Clairways
- "... That's an area of great interest for me is academic founders in the life sciences, taking their technology from the lab into the clinic, or into the market. It requires understanding the technology, and it also requires understanding the market..."
- Verisense
- Xander
- "... Well, he's basically creating a software that interprets the voice of the person who's speaking to the wearer of the glasses, and creates a caption, which projected on the lens. You can caption what people are saying to you..."
- Paul's Backstory
- How Paul Got Into Life Sciences
- 3Com
- "... The whole premise of the technology was that you could take people who were suspect of the disease, and rather than immediately going in for really expensive brain imaging tests, which actually involve exposure to radiation and you can only do them very infrequently, this is something that could be done in a general practitioner's office, doesn't even have to be done in a hospital...:
- Sonivance
- Advice to the Audience
Topics: angel investing strategies, product, venture capital
